Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration
Aging and disease · 2024
DOI: 10.14336/ad.2024.0986 ↗Kurz gefasst
Editorial in der Zeitschrift Aging and disease, 2024. Verfasst von Vivek Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW 2109, Australia. Hauptthemen laut MEDLINE: Aging, Brain, Inflammation, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, Sydney, NSW 2109, Australia.
- School of Medicine, Deakin University, Geelong, VIC 3216, Australia.
Zitieren
APA
Gupta, V., Chitranshi, N., & Gupta, V. B. (2024). Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration. Aging and disease. https://doi.org/10.14336/ad.2024.0986
Vancouver
Gupta V, Chitranshi N, Gupta VB. Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration. Aging and disease. 2024. doi:10.14336/ad.2024.0986
BibTeX
@article{Gupta2024,
author = {Gupta, Vivek and Chitranshi, Nitin and Gupta, Veer Bala},
title = {Genetic Risk, Inflammation, and Therapeutics: An Editorial Overview of Recent Advances in Aging Brains and Neurodegeneration},
journal = {Aging and disease},
year = {2024},
doi = {10.14336/ad.2024.0986}
}
EUVIMED